Test tissue testing right after liver tumor ablation
Part of Cancer, Digestive system clinical trials.
This study looks at liver metastases treated with a procedure that destroys tumors (ablation) and then checks tumor tissue right away. The team wants to see whether the tissue results can guide immediate retreatment to better control cancer in the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have cancer that has spread to the liver (liver metastases)
- Your liver disease is limited to the liver or only a small, stable amount outside the liver for at least 4 months
- You have at least one liver tumor that measures 3 cm or smaller and is active on FDG-PET scan
- Your blood clotting tests are safe: INR is under 1.5 and platelets are 50,000 or higher
- You have no more than 3 liver tumors and no more than 5 tumors outside the liver, and there is no peritoneal carcinomatosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who are having a procedure called thermal ablation to treat liver tumors. It aims to learn more about how well the procedure works and how safe it is.
This trial gives radiation to liver tumors and then takes a small tissue sample (biopsy) to look for changes in the cancer cells after treatment. The goal is to learn what the radiation is doing inside the tumor, which may help improve future treatments.
This study tests a planning and confirmation software tool during a needle-based liver procedure to treat colorectal cancer metastases. It aims to help doctors cover tumors more completely while reducing the chance of leaving tumor tissue behind.
This study tests a new PET scan (Ga-68 Dolacga) to see how well it images liver cancer before you have a standard heat treatment (radiofrequency ablation). The scan may help doctors plan your procedure more precisely.
This trial studies different ways to place treatments inside the liver to control liver tumors when they can’t be removed with surgery or ablation. It may help certain people by improving how well the tumor is treated while keeping liver function safer.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.